DIVE, DIVE, DIVE!! Patience will last only one more

New Post Public Reply Private Reply Replies (1) Message Board
AC143
313
DIVE, DIVE, DIVE!!
Patience will last only one more quarter.
Berman named Class Action back in June 1997. Attorney's for the Plaintiffs.

MILBERG WEISS BERSHAD ORIGINAL HYNES & LERACH LLP
WILLIAM S. LERACH (68581)
PATRICK J. COUGHLIN (111070)
HENRY ROSEN (156963)
KRISTEN McCULLOCH (177558)
600 West Broadway, Suite 1800
San Diego, CA 92101
Telephone: 619/231-1058

EUGENE MIKOLAJCZYK (106929)
1165 N. Bienveneda
Pacific Palisades, CA 90272
Telephone: 310/454-8435

WECHSLER HARWOOD HALEBIAN
& FEFFER LLP
ROBERT I. HARWOOD
RICHARD B. BRUALDI
805 Third Avenue
7th Floor
New York, NY 10022
Telephone: 212/935-7400

DEFENDENTS===>
STEVEN E. LEVY, KEITH M. BERMAN,
JAMES J. KEEGAN, JOHN D. GARBER,
PHILIP BECTON, CORBIN & WERTZ, AND
FENWICK & WEST,
Defendants


Just the beginning of the filing ====>
SUMMARY OF ACTION
2 1. This is an individual and class action on behalf of all
3 persons who purchased the securities of Access HealthNet, Inc.
4 ("Access HealthNet" or the "Company", between January 25, 1995 and
5 December 29, 1995 (the "Class Period" , seeking to pursue remedies
6 under Sections 10(b) and 20(a) of the Securities Exchange Act of
7 1934 ("Exchange Act" and Rule 10b-5 promulgated thereunder (the
8 "Class". This action involves a course of conduct by Access
9 HealthNet insiders, officers and directors of the Company, the
10 Company's auditors and United States Securities and Exchange
11 Commission ("SEC" counsel that was designed to and did defraud
12 those who purchased Access HealthNet securities during the Class
13 Period.
14 2. This case involves defendants' use of manipulative
15 devices and their dissemination of false financial statements and
16 other false and misleading information about Access HealthNet's
17 business, all of which was, inter alia , designed to and did:
18 (a) artificially inflate the price of Access HealthNet securities
19 during the Class Period; (b) induce investors to purchase shares of
20 Access HealthNet stock; (c) allow certain defendants to sell or
21 offer to sell millions of dollars of their own Access HealthNet
22 shares at artificially inflated levels; and (d) allow defendants to
23 sell or offer to sell millions of dollars of Access HealthNet
24 securities to private investors in various private placement
25 transactions.

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Dell Technologies: A Fresh Look at Investor Sentiment Trends

Updated Category News Views 285

Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...

Continue Reading
Compass Diversified Faces Investigation for Securities Violations

Updated Category News Views 173

Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...

Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities

Updated Category News Views 226

Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...

Continue Reading
Growth Prospects of the Global Medical Imaging Reagents Market

Updated Category News Views 148

Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...

Continue Reading
Mike Tyson Teams Up with GBank Financial in New Venture

Updated Category News Views 285

GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...

Continue Reading